The UK’s national synchrotron facility, Diamond Light Source, was used by a large, international collaboration to study grains collected from a near-Earth asteroid to further our understanding of the evolution of our solar system.

Researchers from the University of Leicester brought a fragment of the Ryugu asteroid to Diamond’s Nanoprobe beamline I14 where a special technique called X-ray Absorption Near Edge Spectroscopy (XANES) was used to map out the chemical states of the elements within the asteroid material, to examine its composition in fine detail...

A photoacoustic sensor could help clinicians diagnose tumors, organ malfunction and more. A team of engineers at the University of California San Diego has developed an electronic patch that can monitor biomolecules in deep tissues, including hemoglobin. This gives medical professionals unprecedented access to crucial information that could help spot life-threatening conditions such as malignant tumors, organ dysfunction, cerebral or gut hemorrhages and more.

“The amount and location of hemoglobin in the body provide critical information about blood perfusion or accumulation in ...

For the first time, astronomers have spotted an exoplanet whose orbit is decaying around an evolved, or older, host star. The stricken world appears destined to spiral closer and closer to its maturing star until collision and ultimate obliteration.

The discovery offers new insights into the long-winded process of planetary orbital decay by providing the first look at a system at this late stage of evolution.

Death-by-star is a fate thought to await many worlds and could be the Earth’s ultimate adios billions of years from now as our Sun grows older.

“We’ve previously detected evidence for exoplanets inspiraling toward their stars, but we have never before seen such a planet around an evolved star,” says Shreyas ...

The protein, suPAR, has been found to cause atherosclerosis and kidney disease. Investigators say it’s the first immune target to treat cardiovascular disease, which affects over 1 billion people worldwide. Researchers believe treatment could be developed within five years.

For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and statins.

Despite these measures, heart disease remains the number one cause of death in the United States, with many patients having heart attacks even after their risk factors are controlled, says Salim Hayek, M.D...